Literature DB >> 8018507

Assessment and interpretation of the tubular threshold for phosphate in infants and children.

U Alon1, S Hellerstein.   

Abstract

Studies in the last decade demonstrated that in children tubular maximum phosphate reabsorption per glomerular filtration rate (TmP/GFR) is identical to TP/GFR; TP indicating tubular phosphate reabsorption under basal conditions, without phosphate load. TP/GFR is calculated from the formula TP/GFR = SP-UP x SCr:UCr, based on simultaneous urine and blood creatinine and phosphate concentrations, and is applicable in both the fasting and non-fasting child. These studies also demonstrated that the use of Walton and Bijvoet nomogram in children may result in overestimation of TmP/GFR compared with TP/GFR calculated from the above formula. When using the formula, one should bear in mind that creatinine is used to express GFR and as a result a significant deviation from true GFR may occur in patients with renal failure. Therefore when employing TP/GFR for the investigation of the renal handling of phosphate in children, three factors should be taken into consideration: (1) the formula in reality expresses TP/CCr; (2) only data obtained by exactly the same methodology can be used as reference values; data obtained from studies in which the nomogram was utilized or in which methods other than CCr were used to measure GFR should not be used for reference; (3) in patients with renal failure, TP/CCr will significantly overestimate TP/Cinulin.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8018507     DOI: 10.1007/bf00865491

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  13 in total

1.  Growth and renal control of plasma phosphate.

Authors:  J Corvilain; M Abramow
Journal:  J Clin Endocrinol Metab       Date:  1972-03       Impact factor: 5.958

2.  Renal phosphate excretion in man.

Authors:  O L Bijvoet
Journal:  Folia Med Neerl       Date:  1972

3.  Relation of plasma phosphate concentration to renal tubular reabsorption of phosphate.

Authors:  O L Bijvoet
Journal:  Clin Sci       Date:  1969-08       Impact factor: 6.124

4.  Nomogram for derivation of renal threshold phosphate concentration.

Authors:  R J Walton; O L Bijvoet
Journal:  Lancet       Date:  1975-08-16       Impact factor: 79.321

5.  Indices of intact serum parathyroid hormone and renal excretion of calcium, phosphate, and magnesium.

Authors:  N J Shaw; J Wheeldon; J T Brocklebank
Journal:  Arch Dis Child       Date:  1990-11       Impact factor: 3.791

6.  Renal handling of phosphate in the first six months of life.

Authors:  L Bistarakis; I Voskaki; J Lambadaridis; H Sereti; S Sbyrakis
Journal:  Arch Dis Child       Date:  1986-07       Impact factor: 3.791

7.  Assessment of maximal tubular phosphate reabsorption: comparison of direct measurement with the nomogram of Bijvoet.

Authors:  J Brodehl; A Krause; P F Hoyer
Journal:  Pediatr Nephrol       Date:  1988-04       Impact factor: 3.714

8.  Direct measurement of TP/GFR: a simple and reliable parameter of renal phosphate handling.

Authors:  H Stark; B Eisenstein; M Tieder; A Rachmel; G Alpert
Journal:  Nephron       Date:  1986       Impact factor: 2.847

9.  Creatinine for estimation of glomerular filtration rate.

Authors:  S Hellerstein; U Alon; B A Warady
Journal:  Pediatr Nephrol       Date:  1992-11       Impact factor: 3.714

10.  Postnatal development of tubular phosphate reabsorption.

Authors:  J Brodehl; K Gellissen; H P Weber
Journal:  Clin Nephrol       Date:  1982-04       Impact factor: 0.975

View more
  30 in total

1.  Novel NaPi-IIc mutations causing HHRH and idiopathic hypercalciuria in several unrelated families: long-term follow-up in one kindred.

Authors:  Y Yu; S R Sanderson; M Reyes; A Sharma; N Dunbar; T Srivastava; H Jüppner; C Bergwitz
Journal:  Bone       Date:  2012-02-24       Impact factor: 4.398

2.  Tumor-Induced Osteomalacia.

Authors:  Rajiv Kumar; Andrew L Folpe; Brian P Mullan
Journal:  Transl Endocrinol Metab       Date:  2015

Review 3.  Tumor-induced osteomalacia.

Authors:  William H Chong; Alfredo A Molinolo; Clara C Chen; Michael T Collins
Journal:  Endocr Relat Cancer       Date:  2011-06-08       Impact factor: 5.678

Review 4.  Disorders of phosphate homeostasis and tissue mineralisation.

Authors:  Clemens Bergwitz; Harald Jüppner
Journal:  Endocr Dev       Date:  2009-06-03

5.  Bone mineralization in children with Wilson's disease.

Authors:  Ahmet Cetinkaya; Hasan Ozen; Aysel Yüce; Inci Nur Saltık-Temizel; Hülya Demir; Figen Gürakan
Journal:  Indian J Gastroenterol       Date:  2014-05-25

6.  Phenotypic and Genotypic Characterization and Treatment of a Cohort With Familial Tumoral Calcinosis/Hyperostosis-Hyperphosphatemia Syndrome.

Authors:  Mary Scott Ramnitz; Pravitt Gourh; Raphaela Goldbach-Mansky; Felasfa Wodajo; Shoji Ichikawa; Michael J Econs; Kenneth E White; Alfredo Molinolo; Marcus Y Chen; Theo Heller; Jaydira Del Rivero; Patricia Seo-Mayer; Bita Arabshahi; Malaka B Jackson; Sarah Hatab; Edward McCarthy; Lori C Guthrie; Beth A Brillante; Rachel I Gafni; Michael T Collins
Journal:  J Bone Miner Res       Date:  2016-09-20       Impact factor: 6.741

7.  Hereditary hypophosphatemic rickets with hypercalciuria and nephrolithiasis-identification of a novel SLC34A3/NaPi-IIc mutation.

Authors:  Priya Phulwani; Clemens Bergwitz; Graciana Jaureguiberry; Majjid Rasoulpour; Elizabeth Estrada
Journal:  Am J Med Genet A       Date:  2011-02-22       Impact factor: 2.802

Review 8.  FGF23 and syndromes of abnormal renal phosphate handling.

Authors:  Clemens Bergwitz; Harald Jüppner
Journal:  Adv Exp Med Biol       Date:  2012       Impact factor: 2.622

9.  Proceedings of the American Society of Pediatric Nephrology 1993 Education Symposium, Washington, D.C., 4 May, 1993.

Authors: 
Journal:  Pediatr Nephrol       Date:  1994-10       Impact factor: 3.714

10.  Renal function after ifosfamide, carboplatin and etoposide (ICE) chemotherapy, nephrectomy and radiotherapy in children with Wilms tumour.

Authors:  Najat C Daw; David Gregornik; John Rodman; Neyssa Marina; Jianrong Wu; Larry E Kun; Jesse J Jenkins; Valerie McPherson; Judith Wilimas; Deborah P Jones
Journal:  Eur J Cancer       Date:  2008-11-06       Impact factor: 9.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.